admin

BioCryst Hikes on Q1 Figures

[ad_1] BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares sprinted Monday, on today reported financial results for the first quarter ended March 31, 2025, and provided a corporate update. “We started 2025 with another quarter of outstanding performance. ORLADEYO revenue growth was driven by moving ORLADEYO patients from free drug to paid at a much faster…

Read More